Analysis of anti-implantational action of norethisterone-3-oxime.

Abstract:

:Mature rabbits received norethisterone-3-oxime (NETO) 2 mg/kg/day from day 2 through day 4 of pregnancy by gavage. Control rabbits were given vehicle. All animals were sacrificed on day 5. The oviducts were removed and sections stained with HE. Morphological changes were evaluated. The outer and inner diameters of tubes, and the thickness of circular muscle layers were measured. The layers of the circular muscle cells and the mean thickness occupied by the cytoplasmic mass of the muscle cells were estimated. The fertilized ova flushed out from the oviduct were stained together with the section of ampullary-isthmic junction (AIJ) and isthmus by PAS. The intensity of the staining was observed microscopically and quantified with a microspectrophotometer. NETO treatment led to tortuosity of oviducts showing hyperplasia of epithelial cells and a mucosal edema. The circular muscle layer was thickened but no increase in the number of muscle cells was observed, indicating muscular contraction. Dilatated and congested capillaries appeared in the muscular and subserous layers. All these manifestations were so prominent that the lumen of AIJ and isthmus portion were significantly narrowed as shown by a decreased percentage of inner diameter to outer diameter at AIJ and isthmus. The amount of mucin secreted into the lumen was decreased, but there was an accumulation of mucin in the epithelial cells. The above-mentioned morphological changes lead to the suggestion that the anti-implantational action of NETO is exhibited by its effect on the oviduct in rabbits. Most probably, the action is mainly related to the estrogenic and anti-progestational activity of NETO.

journal_name

Contraception

journal_title

Contraception

authors

Li QG,Li DZ

doi

10.1016/0010-7824(87)90040-0

subject

Has Abstract

pub_date

1987-12-01 00:00:00

pages

667-76

issue

6

eissn

0010-7824

issn

1879-0518

pii

0010-7824(87)90040-0

journal_volume

36

pub_type

杂志文章
  • Study on the factors associated with contraceptive discontinuations in Bangkok.

    abstract::Detailed information was collected from 666 cohorts of pill, injectable-DMPA and IUD acceptors at 14 Bangkok Metropolis Health Clinics (MHCs). The contraceptive status at 12-month follow-up home interview shows that 47% of pill acceptors, 39% of DMPA acceptors and 55% of IUD acceptors were still using the same contrac...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(84)80004-9

    authors: Chumnijarakij T,Sunyavivat S,Onthuam Y,Udomprasertgul V

    更新日期:1984-03-01 00:00:00

  • Quality of postpartum contraceptive counseling and changes in contraceptive method preferences.

    abstract:OBJECTIVES:We examined the association between quality of postpartum contraceptive counseling and changes in contraceptive method preference between delivery and 3-months postpartum. STUDY DESIGN:We used data from 1167 postpartum women delivering at eight hospitals in Texas who did not initiate contraception in the ho...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2019.08.011

    authors: Coleman-Minahan K,Potter JE

    更新日期:2019-12-01 00:00:00

  • Acceptability of the vaginal sheath (Femshield) in Thai couples.

    abstract::A small survey to assess the perception and experience of current family planning users and their husbands was carried out in a university family planning clinic. Women routinely visiting the clinic were asked to complete a short Screening Form. Fifty-six women responded to the questionnaire concerning their attitude ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(91)90118-y

    authors: Jivasak-Apimas S

    更新日期:1991-08-01 00:00:00

  • Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.

    abstract:OBJECTIVES:To measure the 24-month impact on continuation, unintended pregnancy and satisfaction of trying long-acting reversible contraception (LARC) in a population seeking short-acting reversible contraception (SARC). STUDY DESIGN:We enrolled 916 women aged 18-29 who were seeking pills or injectables in a partially...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2018.02.001

    authors: Hubacher D,Spector H,Monteith C,Chen PL

    更新日期:2018-06-01 00:00:00

  • The promise and reality of the intrauterine route for hormone delivery for prevention and therapy of gynecological disease.

    abstract:CONTEXT:Progestins delivered by a variety of routes have been demonstrated, in addition to their high contraceptive effect, to have substantial benefits in the treatment of various gynecological disorders, and the intrauterine route has particular efficacy in treating endometrial and myometrial disorders. It should be ...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2006.12.013

    authors: Fraser IS

    更新日期:2007-06-01 00:00:00

  • Phase I clinical trials with three formulations of anti-human chorionic gonadotropin vaccine.

    abstract::Comparative phase I clinical trials were carried out in 5 centres with three formulations of beta-hCG-based vaccines inducing antibodies against human chorionic gonadotropin. The objectives of these trials were to determine their relative immunogenicity, duration, reversibility and safety. A total of 116 tubal ligated...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/0010-7824(90)90071-3

    authors: Talwar GP,Hingorani V,Kumar S,Roy S,Banerjee A,Shahani SM,Krishna U,Dhall K,Sawhney H,Sharma NC

    更新日期:1990-03-01 00:00:00

  • Reversible changes in the content of cellular and microtubular tubulin in spermatogenic cells after gossypol treatment.

    abstract::After exposure of young male rats to gossypol acetic acid for various times, a reduction in the content of cellular and microtubular beta-tubulin was found in spermatocytes and spermatids. The content of tubulin was measured by enzyme-linked immunosorbent assay (ELISA). The results were expressed as micrograms tubulin...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(96)00240-5

    authors: Teng CS

    更新日期:1997-01-01 00:00:00

  • Medication Abortion Up to 70 Days of Gestation.

    abstract::Medication abortion, also referred to as medical abortion, is a safe and effective method of providing abortion. Medication abortion involves the use of medicines rather than uterine aspiration to induce an abortion. The U.S. Food and Drug Administration (FDA)-approved medication abortion regimen includes mifepristone...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2020.08.004

    authors: Practice Bulletins—Gynecology, the Society of Family Planning.

    更新日期:2020-10-01 00:00:00

  • Recent progress in research on Tripterygium: a male antifertility plant.

    abstract::The discovery of the reversible antifertility action of an extract from Tripterygium wilfordii both in male rats and in men in 1986 stimulated worldwide interest. International and national collaborations aimed at the bioassay-directed sub-fractionation of materials extracted from the plant was then organized and to d...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(94)00018-r

    authors: Zhen QS,Ye X,Wei ZJ

    更新日期:1995-02-01 00:00:00

  • Latin american experience with two low-dose oral contraceptives containing 30 microg ethinylestradiol/75 microg gestodene and 20 microg ethinylestradiol/150 microg desogestrel.

    abstract::The objective of this study was to compare cycle control, efficacy and tolerance of an oral contraceptive containing 20 microg ethinylestradiol and 150 microg desogestrel with a preparation containing 30 microg ethinylestradiol combined with 75 microg gestodene. This study involved 342 women and 4104 cycles use in Arg...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/s0010-7824(00)00153-0

    authors: Bassol S,Alvarado A,Celis C,Cravioto MC,Peralta O,Montaño R,Novelli J,Albornoz H,Kesseru E,Soares A,Petracco A,Isaia B,Mendes J,Bahamondes L,de Melo NR,Reyes-Marquez R,Albrecht G

    更新日期:2000-09-01 00:00:00

  • Levels of contraceptive seroids in breast milk and plasma of lactating women.

    abstract::Levels of contraceptive steroids in breast milk and plasma of lactating women were investigated. 7 lactating women received 150 mg medroxyprogesterone acetate (MPA) 1 week after delivery. 5 women (lactating) took 350 mcg norethisterone (NET) and 2 took 150 mcg d-norgestrel (d-ng) + 30 mcg ethinyl estradiol. Milk an...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(77)90061-0

    authors: Saxena BN,Shrimanker K,Grudzinskas JG

    更新日期:1977-12-01 00:00:00

  • Metabolic investigations with Femodene--an oral contraceptive containing gestodene and ethinyloestradiol.

    abstract::The metabolic effects of a new oral contraceptive Femodene (SHD 356C) containing 75 micrograms gestodene (delta-15-levonorgestrel) and 30 micrograms ethinyloestradiol were studied in two groups of women. Group 1 consisted of women not currently using oral contraceptives; Group 2 consisted of women switching to Femoden...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(87)90069-2

    authors: Fotherby K,Trayner I,Longthorne PN,Lee B,Watson HR

    更新日期:1987-04-01 00:00:00

  • Cyproterone acetate affects protamine gene expression in the testis of adult male rat.

    abstract::The temporal effects of oral administration of cyproterone acetate (CPA), a progestational androgen receptor blocker, were studied on the fertility of adult male rat sires, at a dose of 20 mg kg-1 day-1 after 15 days of gavage. The treatment reduced the fertility and weights of accessory sex glands, without altering t...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2004.11.003

    authors: Aleem M,Padwal V,Choudhari J,Balasinor N,Parte P,Gill-Sharma M

    更新日期:2005-05-01 00:00:00

  • A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.

    abstract::In this open-label, randomized study we compared the influence of a new oral contraceptive containing 30 microg ethinylestradiol and 3 mg drospirenone (EE + DRSP = Yasmin), with a reference preparation containing 30 microg ethinylestradiol and 150 microg desogestrel (EE + DSG = Marvelon) on the lipid profile. The prim...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.contraception.2003.11.003

    authors: Gaspard U,Endrikat J,Desager JP,Buicu C,Gerlinger C,Heithecker R

    更新日期:2004-04-01 00:00:00

  • A Bridge for postpartum women to Standard Days Method®: I. Developing the Bridge.

    abstract:BACKGROUND:A new fertility-awareness-based Bridge was developed for postpartum women starting with their first postpartum menses and until they are eligible to use the Standard Days Method®. This article describes the development of the Bridge and theoretical efficacy. STUDY DESIGN:Analysis of a preexisting data set c...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2011.11.009

    authors: Sinai I,Cachan J

    更新日期:2012-07-01 00:00:00

  • Weight and body mass index among female contraceptive clients.

    abstract:OBJECTIVES:As obesity may affect the efficacy of some contraceptives, we examined weight, body mass index (BMI) and prevalence of obesity among female contraceptive clients at 231 U.S. health centers. A secondary aim was to analyze differences in contraceptive method use by obesity status. STUDY DESIGN:Cross-sectional...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2015.02.006

    authors: Kohn JE,Lopez PM,Simons HR

    更新日期:2015-06-01 00:00:00

  • Anti-implantation activity of luteal phase mifepristone administration is not mimicked by prostaglandin synthesis inhibitor or prostaglandin analogue in the rhesus monkey.

    abstract::The use of mifepristone as an anti-implantation agent in the primate has been explored in the rhesus monkey with two specific aims: (i) to determine the contraceptive efficacy of very low-dose mifepristone administered on mated cycle days 16, 17, and 18; and (ii) to test the hypothesis that alteration in endometrial p...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(96)00280-6

    authors: Nayak NR,Ghosh D,Lasley BL,Sengupta J

    更新日期:1997-02-01 00:00:00

  • Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies.

    abstract:BACKGROUND:The study was conducted to characterize the changes in bleeding pattern over time in women receiving the levonorgestrel-releasing intrauterine system (LNG-IUS) for heavy menstrual bleeding (HMB). The reduction in menstrual blood loss volume has been well documented elsewhere. STUDY DESIGN:Post hoc pooled an...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2012.08.022

    authors: Jensen J,Mansour D,Lukkari-Lax E,Inki P,Burock K,Fraser IS

    更新日期:2013-01-01 00:00:00

  • An initial pharmacokinetic study with a Metered Dose Transdermal Systemfor delivery of the progestogen Nestorone as a possible future contraceptive.

    abstract:BACKGROUND:Transdermal delivery of steroids is gaining popularity for contraception and hormone replacement therapy. This study aimed to test metered spray delivery of a precise dosage of Nestorone (NES) progestogen as a possible transdermal progestogen-only contraceptive. STUDY DESIGN:Six healthy postmenopausal volun...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2007.08.006

    authors: Fraser IS,Weisberg E,Kumar N,Kumar S,Humberstone AJ,McCrossin L,Shaw D,Tsong YY,Sitruk-Ware R

    更新日期:2007-12-01 00:00:00

  • The effect of levonorgestrel-releasing intrauterine device on menorrhagia in women taking anticoagulant medication after cardiac valve replacement.

    abstract:BACKGROUND:This study was conducted to evaluate the effect of levonorgestrel-releasing intrauterine devices (LNG-IUDs) on menorrhagia in patients receiving anticoagulant therapy after cardiac valve replacement. STUDY DESIGN:Forty women with menorrhagia who underwent cardiac valve replacement and were taking anticoagul...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2009.02.007

    authors: Kilic S,Yuksel B,Doganay M,Bardakci H,Akinsu F,Uzunlar O,Mollamahutoglu L

    更新日期:2009-08-01 00:00:00

  • A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.

    abstract:OBJECTIVES:To evaluate the impact on lipid and carbohydrate variables of a combined one-third ethinyl estradiol (EE)/levonorgestrel (LNG) dose reduction in oral contraceptives. METHODS:In an open-label, randomized study, a dose-reduced oral contraceptive containing 20 microg EE and 100 microg LNG (20 EE/100 LNG) was c...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.contraception.2004.08.017

    authors: Skouby SO,Endrikat J,Düsterberg B,Schmidt W,Gerlinger C,Wessel J,Goldstein H,Jespersen J

    更新日期:2005-02-01 00:00:00

  • Safety and efficacy of a triphasic oral contraceptive containing desogestrel: results of three multicenter trials.

    abstract::This report combines the data obtained in three multicenter efficacy studies with a new triphasic oral contraceptive combination containing desogestrel (DSG) and ethinyl estradiol (EE). The studies were conducted at 40 investigational sites in the United States (38 centers) and Canada (2 centers) in support of the FDA...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/0010-7824(93)90078-l

    authors: Darney P

    更新日期:1993-10-01 00:00:00

  • Postovulatory contraception in women with large doses of norethindrone.

    abstract::To test the contraceptive efficacy of norethindrone (NET), the effect of NET on peripheral plasma levels of progesterone and estradiol after ovulation was investigated, since low levels of ovarian steroids might affect the postovulatory endometrium and thereby impair normal blastocyst implantation. Two studies were ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(72)90011-x

    authors: Nygren KG,Johansson ED,Wide L

    更新日期:1972-06-01 00:00:00

  • A single-blinded randomized controlled trial evaluating pain and opioid use after dilator placement for second-trimester abortion.

    abstract:OBJECTIVES:To compare pain levels and medication needs after placement of laminaria vs Dilapan-S, and after dilation and evacuation (D&E). STUDY DESIGN:We conducted a single-blinded randomized control trial of patients undergoing D&E at 15 0/7 to 23 6/7 weeks gestation, randomizing to cervical preparation with laminar...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2020.11.014

    authors: Liu SM,Flink-Bochacki R

    更新日期:2020-12-04 00:00:00

  • Bleeding patterns of adolescents using a combination contraceptive injection for 1 year.

    abstract:PURPOSE:This prospective observational study evaluated the bleeding patterns of adolescents receiving a monthly injectable contraceptive containing norethisterone enanthate 50 mg plus estradiol valerate 5 mg. MATERIALS AND METHODS:The study enrolled 73 volunteers aged between 14 and 19 years; of these patients, 38 (52...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2006.01.009

    authors: Bortolotti de Mello Jacobucci MS,Guazzelli CA,Barbieri M,Araújo FF,Moron AF

    更新日期:2006-06-01 00:00:00

  • Interaction of anticonvulsants and oral contraceptives in epileptic adolescents.

    abstract::Oral contraceptives are in widespread use, and are commonly prescribed for contraception in patients taking other medications. An example of this is the concomitant use of oral contraceptives and anticonvulsants in epileptic patients. This combination creates a potential for drug interactions which may alter the effic...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(85)90062-9

    authors: Diamond MP,Greene JW,Thompson JM,VanHooydonk JE,Wentz AC

    更新日期:1985-06-01 00:00:00

  • Availability of pharmacist prescription of contraception in rural areas of Oregon and New Mexico.

    abstract:OBJECTIVE:To determine the availability of pharmacist prescribing of hormonal contraception in rural areas of two states. STUDY DESIGN:Cross-sectional survey. RESULTS:Overall, 42% of pharmacies prescribed contraception (Oregon: 46% and New Mexico 19%). A similar proportion of rural pharmacies reported offering pharma...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2019.11.005

    authors: Rodriguez MI,Garg B,Williams SM,Souphanavong J,Schrote K,Darney BG

    更新日期:2020-03-01 00:00:00

  • Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD.

    abstract::Plasma concentrations of levonorgestrel, progesterone, estradiol, FSH and LH were measured in seven volunteers who had a levonorgestrel-releasing IUD inserted postmenstrually. Blood samples were collected twice weekly during a mean of 93 days immediately postmenstrually and during a mean of 41 days over the twelfth to...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(80)90003-7

    authors: Nilsson CG,Lähteenmäki P,Luukkainen T

    更新日期:1980-03-01 00:00:00

  • Introduction of cyclofem once-a-month injectable contraceptive in Mexico.

    abstract::A large introductory study of Cyclofem, a once-a-month injectable contraceptive, was conducted in three Mexican provinces. A total of 3457 healthy women participated: 640 women from rural areas (community-based component) and 2817 women from urban and suburban areas (health center-based component). A total of 20,316 w...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0010-7824(98)00062-6

    authors: Garza-Flores J,Moraks del Olmo A,Fuziwara JL,Figueroa JG,Alonso A,Monroy J,Perez M,Urbina-Fuentes M,Guevara SJ,Cedeno E,Barrios R,Ferman JJ,Medina LM,Velazquez E,Perez-Palacios G

    更新日期:1998-07-01 00:00:00

  • The efficacy and acceptability of a low-dose levonorgestrel intravaginal ring for contraception in a UK cohort.

    abstract::The efficacy and acceptability of a levonorgestrel-releasing intravaginal ring (IVR) for contraception was assessed in a British cohort studied as part of a multicentre, multinational clinical trial performed under the auspices of the World Health Organisation. One-hundred-and-fifty women took part in the study in two...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/0010-7824(91)90040-m

    authors: Elder MG,Lawson JP,Elstein M,Nuttall ID

    更新日期:1991-02-01 00:00:00